VeriMomhydrogenated tallowamide dea hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
Related ingredients
Frequently asked questions
- hydrogenated tallowamide dea hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
- hydrogenated tallowamide dea emzirirken güvenli mi?
- Same evidence basis as for pregnancy: no harmonised classification or specific reproductive/developmental toxicity data were located for this CAS. Theoretical class concerns about DEA‑type substances (e.g., formation of nitrosamines or residual free DEA) are noted in broader DEA discussions but are not specific toxicological proof for this substance. Dermal exposure from cosmetics is low‑to‑measurable; breastfeeding exposure via milk is not demonstrated in the literature for this ingredient.
- hydrogenated tallowamide dea bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental data were identified. Infant skin has higher surface‑area‑to‑weight and immature barrier function, so exposure score is increased by +1 relative to adult (adult e=1 → infant e=2) despite lack of data showing systemic effects. No evidence found that the ingredient is banned/restricted for infant use under EU Cosmetic Regulation.
- VeriMom hydrogenated tallowamide dea nasıl puanlıyor?
- VeriMom hydrogenated tallowamide dea'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hydrogenated tallowamide dea yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.